The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid
Abstract
BACKGROUND: Bullous pemphigoid is the most common autoimmune blistering skin disease of the elderly. Because elderly people have low tolerance for standard regimens of oral corticosteroids, we studied whether highly potent topical corticosteroids could decrease mortality while controlling disease. METHODS: A total of 341 patients with bullous pemphigoid were enrolled in a randomized, multicenter trial and stratified according to the severity of their disease (moderate or extensive). Patients were randomly assigned to receive either topical clobetasol propionate cream (40 g per day) or oral prednisone (0.5 mg per kilogram of body weight per day for those with moderate disease and 1 mg per kilogram per day for those with extensive disease). The primary end point was overall survival. RESULTS: Among the 188 patients with extensive bullous pemphigoid, topical corticosteroids were superior to oral prednisone (P=0.02). The one-year survival rate was 76 percent in the topical-corticosteroid group and 58 percent in the oral-prednisone group. Disease was controlled at three weeks in 92 of the 93 patients in the topical-corticosteroid group (99 percent) and 86 of the 95 patients in the oral-prednisone group (91 percent, P=0.02). Severe complications occurred in 27 of the 93 patients in the topical-corticosteroid group (29 percent) and in 51 of the 95 patients in the oral-prednisone group (54 percent, P=0.006). Among the 153 patients with moderate bullous pemphigoid, there were no significant differences between the topical-corticosteroid group and the oral-prednisone group in terms of overall survival, the rate of control at three weeks, or the incidence of severe complications. CONCLUSIONS: Topical corticosteroid therapy is effective for both moderate and severe bullous pemphigoid and is superior to oral corticosteroid therapy for extensive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning and Primary Structural Analysis of the Bullous Pemphigoid Autoantigen BP180
Giudice, G. J., Emery, D. J., & Diaz, L. A. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616580 · Cited by 568
Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions
Bernard, P. (1995) · Archives of Dermatology · doi:10.1001/archderm.1995.01690130050009 · Cited by 438
Self-citationDiaz, L. A., Ratrie, H., Saunders, W. S., Futamura, S., Squiquera, H. L., Anhalt, G. J., & Giudice, G. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114812 · Cited by 368
The Use of the Karnofsky Performance Scale in Determining Outcomes and Risk in Geriatric Outpatients
Crooks, V., Waller, S., Smith, T., & Hahn, T. J. (1991) · Journal of Gerontology · doi:10.1093/geronj/46.4.m139 · Cited by 336
Bernard, P. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.1.48 · Cited by 300
Self-citationGammon, W. R., Kowalewski, C., Chorzelski, T. P., Kumar, V., Briggaman, R. A., & Beutner, E. H. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70094-x · Cited by 204
Snow, J. L. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.2.193 · Cited by 144
EFFECTS OF CYCLOSPORIN ON BULLOUS PEMPHIGOID AND PEMPHIGUS
Thivolet, J., Barthélémy, H., Rigot‐Muller, G., & Bendelac, A. S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91099-2 · Cited by 133
Bullous pemphigoid treated with mycophenolate mofetil
Böhm, M., Beissert, S., Schwarz, T., Metze, D., & Luger, T. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80092-x · Cited by 129
Management of Acquired Bullous Skin Diseases
Fine, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332207 · Cited by 119
The Complications of Systemic Corticosteroid Therapy in the Elderly
Thomas, T. (2009) · Gerontology · doi:10.1159/000212608 · Cited by 94
Azathioprine plus prednisone in treatment of pemphigoid.
Burton, J. L., Harman, R. R., Peachey, R. D. G., et al. (1978) · BMJ · doi:10.1136/bmj.2.6146.1190 · Cited by 93
Cited by
Schmidt, E., & Zillikens, D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61140-4 · Cited by 1,015
Sommermeyer, D., Hudecek, M., Kosasih, P. L., Gogishvili, T., Maloney, D. G., Turtle, C. J., & Riddell, S. R. (2016) · Leukemia · doi:10.1038/leu.2015.247 · Cited by 867
Langan, S. M., Smeeth, L., Hubbard, R., Fleming, K. M., Smith, C. J. P., & West, J. (2008) · BMJ · doi:10.1136/bmj.a180 · Cited by 632
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Feliciani, C., Joly, P., Jonkman, M. F., Zambruno, G., Zillikens, D., Ioannides, D., Kowalewski, C., Jedlickova, H., Kárpáti, S., Marinovic, B., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13717 · Cited by 314
Self-citation
Metadata
- Authors
- Joly, P., Roujeau, J.-C., Benichou, J., Picard, C., Dreno, B., Delaporte, E., Vaillant, L., D'Incan, M., Plantin, P., Bedane, C., Young, P., & Bernard, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-01-31
- Volume
- 346
- Issue
- 5
- Pages
- 321-327
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2072785143
- Cited by
- 626
- References
- 12
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.